BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 30632069)

  • 1. Uridine phosphorylase-1 promotes cell viability and cell-cycle progression in human epidermal keratinocytes via the glycolytic pathway.
    Xiao X; Qiu T; Cheng Q; Wang W; Fan C; Zuo F
    Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13874. PubMed ID: 38797519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MIR181A2HG negatively regulates human keratinocytes proliferation by binding SRSF1.
    Fan X; Li M; Niu M; Chen F; Mo Z; Yue P; Wang M; Liu Q; Liang B; Gan S; Weng C; Gao J
    Cytotechnology; 2024 Jun; 76(3):313-327. PubMed ID: 38736729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxyresveratrol Inhibits TNF-α-Stimulated Cell Proliferation in Human Immortalized Keratinocytes (HaCaT) by Suppressing AKT Activation.
    Wikan N; Hankittichai P; Thaklaewphan P; Potikanond S; Nimlamool W
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in IL36G gene are associated with plaque psoriasis.
    Traks T; Keermann M; Prans E; Karelson M; Loite U; Kõks G; Silm H; Kõks S; Kingo K
    BMC Med Genet; 2019 Jan; 20(1):10. PubMed ID: 30634937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular consideration relevant to the mechanism of the comorbidity between psoriasis and systemic lupus erythematosus (Review).
    Qu Y; Li D; Liu W; Shi D
    Exp Ther Med; 2023 Oct; 26(4):482. PubMed ID: 37745036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of selected genetic variants in psoriasis susceptibility and response to treatment.
    Malinowski D; Białecka M; Bojko P; Kiszkielis A; Droździk M; Kurzawski M
    Postepy Dermatol Alergol; 2022 Oct; 39(5):934-939. PubMed ID: 36457676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a bioinformatics study.
    Li AH; Chen YQ; Chen YQ; Song Y; Li D
    J Int Med Res; 2022 Aug; 50(8):3000605221117138. PubMed ID: 35949173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of
    Qin M; Chen W; Li Z; Wang L; Ma L; Geng J; Zhang Y; Zhao J; Zeng Y
    J Vet Sci; 2021 May; 22(3):e39. PubMed ID: 34056880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of psoriasis by continuous neutrophil infiltration into the epidermis.
    Katayama H
    Exp Dermatol; 2018 Oct; 27(10):1084-1091. PubMed ID: 30019426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL28RA inhibits human epidermal keratinocyte proliferation by inhibiting cell cycle progression.
    Yin X; Zhang S; Li B; Zhang Y; Zhang X
    Mol Biol Rep; 2019 Feb; 46(1):1189-1197. PubMed ID: 30632069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-125a Correlates with Decreased Psoriasis Severity and Inflammation and Represses Keratinocyte Proliferation.
    Su F; Jin L; Liu W
    Dermatology; 2021; 237(4):568-578. PubMed ID: 33735868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-22-induced miR-122-5p promotes keratinocyte proliferation by targeting Sprouty2.
    Jiang M; Ma W; Gao Y; Jia K; Zhang Y; Liu H; Sun Q
    Exp Dermatol; 2017 Apr; 26(4):368-374. PubMed ID: 27943426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Keratinocyte Transcriptome in Psoriasis: Pathways Related to Immune Responses, Cell Cycle and Keratinization.
    Pasquali L; Srivastava A; Meisgen F; Das Mahapatra K; Xia P; Xu Landén N; Pivarcsi A; Sonkoly E
    Acta Derm Venereol; 2019 Feb; 99(2):196-205. PubMed ID: 30320872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-223 regulates proliferation and apoptosis of IL-22-stimulated HaCat human keratinocyte cell lines via the PTEN/Akt pathway.
    Wang R; Wang FF; Cao HW; Yang JY
    Life Sci; 2019 Aug; 230():28-34. PubMed ID: 31108094
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.